Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $97.9400 (-1.35%) ($96.8100 - $99.7800) on Thu. Jul. 9, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.7% (three month average) | RSI | 59 | Latest Price | $97.9400(-1.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.2% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(50%) SPLV(38%) VYM(36%) DIA(34%) IVE(33%) | Factors Impacting ABBV price | ABBV will decline at least -0.85% in a week (0% probabilities). VIXM(-24%) UUP(-9%) VXX(-6%) TLT(-3%) XLC(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.85% (StdDev 1.7%) | Hourly BBV | -1.2 () | Intraday Trend | -1.1% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $98.89(-0.96%) | 10 Day Moving Average | $98.19(-0.25%) | 20 Day Moving Average | $96.8(1.18%) | To recent high | -1.4% | To recent low | 22.8% | Market Cap | $172.794b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |